• HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE
  • HealthTech 250
  • Our Solutions
    • HealthTech Alpha
    • Innovation Playbook
      • Digital Health Landscape Readiness Assessment
      • Competitive Benchmarking
      • Digital Health Portfolio Review
      • Next Gen Scouting
  • Our Work
  • Who We Help
    • Lifesciences
    • Insurance
    • Investors
  • Research
  • Events
  • About Us
SUBSCRIBE

Macro and micro-environment analysis in RWD & RWE

Assessment of the macro and micro-environment for Real World Data and Real Word Evidence for a Pharma CVC

Vertical : Investors

Ecosystems : Key Asia Pacific market

Solution:

  • Digital Health Landscape Readiness Assessment
  • Next Gen Scouting

Objective

The Corporate Venture Capital (CVC) arm of a global pharmaceutical company wanted to analyse a specific key APAC market to assess both the macro and micro-environment for Real World Data and Real Word Evidence to inform corporate strategy and prioritise key ventures for further engagement. By utilising Galen Growth's proven PlayBook methodology, we enabled our client to fully understand the RWD and RWE innovation environment and readiness to enable the identification and prioritisation of Digital Health ventures with the right capabilities and achievements. Further prioritisation driven by Deep Dive analysis of select ventures, to map their operating model, leading to direct engagement with their leadership team. The examination covered 1 key therapeutic area in 1 key APAC country. We screened 15 ventures and, in collaboration with our client, shortlisted 7.

Outcomes

The data, intel and insights from this comprehensive analysis allowed our investor client to better understand the digital health landscape of this key APAC market, identify “ready-made” RWE integrated solutions and develop appropriate scenarios / options for potential “integrated solutions” models where these are potentially complimentary.

Key Results

Number of countries 1
Number of therapeutic areas 1
Number of ventures screened 15
Number of ventures shortlisted 7

Take The Next Step

Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth

Subscribe to our ecosystem news

Sign up to join the only global HealthTech community.

Subscribe

HealthTech Alpha
Privacy policy
Terms

About us
Contact us
Privacy policy
Terms

Innovation Playbook
Healthtech alpha
Events
Research

Galen Growth Asia Singapore

Galen Growth Europe Switzerland

Galen Growth N. America USA

© Galen Growth 2023

Overview

Category

Stage

Total Funding

GGA Score

powered by
See Full Startup Profile